Funded Tech Companies
Tubulis
Wondering who provided funding to Tubulis? Evotec, OCCIDENT and Nextech Invest joined the equity holders in this innovative life sciences company.
Company Overview
Company Name
Tubulis
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Butenandtstraße 1
Munich, 81377
Germany
Munich, 81377
Germany
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/14/2024
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dominik Schumacher
Chief Marketing Officer
Günter Fingerle-Rowson
Chief Scientific Officer
Jonas Helma-Smets
Vice President
Olivier Marcq
VP - Bus. Development
Ingo Lehrke
VP - Regulatory Affairs
Armin Weidmann
Company Investors
- Evotec
- OCCIDENT
- Nextech Invest (Kanishka Pothula)
- Coparion
- Andera Partners (Sofia Ioannidou)
- Frazier Life Sciences
- Bayern Kapital
- BioMedPartners
- Deep Track Capital
- High-Tech Gründerfonds
- Seventure Partners
- EQT Life Sciences (Christoph Broja)
- Fund+
Browse more funded tech companies:
Tubular Labs | Tucker Powersports
Share this article
About Our VC Funding Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs